US$ 27.50
glp 1 agonist and dementia Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders Glucagon like peptide-1 (GLP-1) likes
Description
Sodium-Glucose Co-Transporter 2 Inhibition with Empagliflozin Improves Cardiac Function in Non-Diabetic Rats with Left Ventricular Dysfunction after Myocardial Infarction

Hellenic J Psychol
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice

For instance, Liraglutide, popularly known as Victoza or Saxenda, has been approved specifically for weight loss by the FDA

This is not a rejection of GLP-1s

H., Jin, G
